Bird’s Eye View on Mycobacterium tuberculosis –HIV Coinfection: Understanding the Molecular Synergism, Challenges, and New Approaches to Therapeutics
ACS Infectious Diseases · 2025
DOI: 10.1021/acsinfecdis.4c00870 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift ACS Infectious Diseases, 2025. Verfasst von Siranjeevi Rangaraj und 2 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Molecular Pathogenesis, Department of Biochemistry, School of Life Sciences, University of Hyderabad, Hyderabad, Telangana 500046, Indi…. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, HIV Infections, Coinfection, Tuberculosis. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 228 Literaturangaben. Gefördert von: DBT-JA National Women Bioscience Award.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Molecular Pathogenesis, Department of Biochemistry, School of Life Sciences, University of Hyderabad, Hyderabad, Telangana 500046, India.
ORCID-Profile: Sharmistha Banerjee
Förderung
- DBT-JA National Women Bioscience Award
Zitieren
APA
Rangaraj, S., Agarwal, A., & Banerjee, S. (2025). Bird’s Eye View on Mycobacterium tuberculosis –HIV Coinfection: Understanding the Molecular Synergism, Challenges, and New Approaches to Therapeutics. ACS Infectious Diseases. https://doi.org/10.1021/acsinfecdis.4c00870
Vancouver
Rangaraj S, Agarwal A, Banerjee S. Bird’s Eye View on Mycobacterium tuberculosis –HIV Coinfection: Understanding the Molecular Synergism, Challenges, and New Approaches to Therapeutics. ACS Infectious Diseases. 2025. doi:10.1021/acsinfecdis.4c00870
BibTeX
@article{Rangaraj2025,
author = {Rangaraj, Siranjeevi and Agarwal, Anushka and Banerjee, Sharmistha},
title = {Bird’s Eye View on Mycobacterium tuberculosis –HIV Coinfection: Understanding the Molecular Synergism, Challenges, and New Approaches to Therapeutics},
journal = {ACS Infectious Diseases},
year = {2025},
doi = {10.1021/acsinfecdis.4c00870}
}
EUVIMED